Member Info for MaxHSpringer

Dryland- not confirming or rejecting sweepie's post! However, the mm's have dropped the price with good demand and good volume!
Those who sold this morning (for the most part will not be able to get in at current prices and turn a profit
If the people who sold this morning try and buy in again, they will have less shares.
As well chartists are saying that #DMTR has gone above the upper bollinger band!
For me this is bout to move up to the next resistance

Orhy- all that means is that you bought under the mid point between the bid and ask- so you got a got them cheap, well done!

OB 10-15p by Christmas is doable! More is also possible, but it all depends on news.
I have heard Phizzer mentioned as a possible deal as well, buy again until it's rns'd it's only hear say!
I have however been told by the company that a lot is happening, so I take that as positive sign.

The trick in my opinion as mentioned earlier is to roll this out to as many Pharma's as possible to increase it's chances of becoming an industry standard!
If you can get it to the point where Pharma's recognized Deepmatter products as a "must have", then we are certainly onto a very big winner!

My father worked very hard only to die a year after retiring! But, he did like his electronics.
I remember he had a quadraphonic stereo in the 70's (basically dolby effect) with four speakers that were placed each in a corner of a square room. If you sat in the middle of the four speakers it really emersed you in the sound,but it was only a small sweet spot!

I think people find money for the things they find important to them: caravens, cars, holidays....

Now as far as DMTR is concerned . I think that we have a big advantage as a company.
As companies take up the technology, they will input and build many hours of experiments that will have to be redone if they changed to another system.
This in my opinion is the advantage of being one of the first (if not the first).
I can only imagine that once a pharma adopts a system, they would be very reluctant to change and this is where Deepmatter must at all cost maximize this window and the current collaborations!

That shows how expensive they were as in the northeast that would've been a big chunk toward a deposit on a house, lol!

My wife only paid £25k for her first house in 1999, lol

Beta cassettes were actually smaller than VHS.
The quality was.

even better, but what killed beta were two major factors
1) cost of the units! Sony betamax's players were much more expensive than the VHS's
2) a VHS cassette had .ore speeds and you could record for up to 6hrs (although do seem to remember the quality suffered for longer recordings)

But to be fair beta did have a market for professional use.

We had both but I remember that movies started being released more in VHS format than in beta! I guess that was to do with more people buying the VHS machines purely on cost and as a result more market for content.

I remember as a kid/teenager going down to the video shop and renting movies! That was a great night in or with friends!

Hi OB/Riddler,
Covid is the difference here and in this type of industry, I would not be surprised if things are further along than initially planned!
Covid has made the matured the need and now a greater understanding of this and as a result, I can see a greater demand than where we would otherwise have been!
Just a thought, but I would imagine that we will soon hear from the company

OB!

I hope you have a good Sunday Dinner! The kids and the Mrs are out ND I am here with the dogs watching old Gabriel Iglesias videos (in stitches)

As far as DMTR is concerned it is dificult to put a figure on it, but can say this (imo).
Each license costs $25-$100k/yr (£20-£80k'ish)
So, if you get a few of the big Pharma's to take up 50-100 licenses this would be somewhere between £1m- £80m, per pharma.
However I would think that they would want to trial it and see what kind of result they get in order to extrapolate the true benefit to their company.
So, I would imagine that the big boys would initially start with somewhere between 4-20 licenses and then evaluate and roll it out.

There are also smaller Pharma's that would be interested because on one hand they would have a smaller budget but then if this saves them time and money, it would be a no briñer if they get pharmaceutical from discovery, development, trial ND to market.
Now, I would imagine that the company might have to give some kind of sweetener in order to get this in more labs faster (such as discounts or upgrades)
There is also Covid and how this technology is probably of more interest and demand, so (shooting from the hip and not having important details).
If I had to guess it would be somewhere between $2m-$10m

That's my guestimate based on previous and extensive sales experience.
If we get more, than happy days but anything between £1.6m- £8m would where id say!
This is just an opinion so hope it helps!

Coca-Cola Vs Pepsi!
Coca-Cola came first and rolled out far enough that Pepsi never quite caught up!
However, beta vs VHS was simply a matter that more people had VHS and it got to the point where the industry had to choose.
Essentially they did the same thing but beta we more expensive

Now, in this case- it seems that both systems essentially do two different things.
The IBM platform USP is to read patents and figure out how to replicate that! (As I understand it).

Where as DigitalGlassware takes all the readings of a reaction and replicates the formula. In addition DigitalGlassware allows you to cut the labour intensiveness of building complex molecules (where I can't really see the IBM system quite doing that)
As far as the chemputer side the idea would be to have one in every pharamacy in order to 3D print precise medication.
This could be a game changer for the ability to tailor treatment to the individual patient!
This is a game changer and would allow advances in medicine from the point of view of treatment.
Another thought is that of Orphan mendications/illnesses that are currently not addressed or under servixed because the drug companies find them to be to expensive to develop for the current markets
Manufacturing, sticking, selling and distribution is expensive and this technology would cut all that out, this making more treatments available for those patients.
At this point it would be interesting to see what patents protect which system!
So, if they are two different tools doing two different things or is one and the other basically the same and which would have more useful features and which one would allow real world to do more, then price would come into it as well.

It hasn't been done as I couldn't get the guy I use out. There is more urgent work that will be done on another house this coming week, but he is chucker blocked at moment. Has work pent up from lockdown

There isn't much free float here and as a result you may expect some tree shakes and sometimes mm's night only show the sells in order to get shares for the healthy buys that may be delayed. Simply because the mm will not have the shares! Don't be fouled !

OB! There are multi millionaires who were janitors and secretaries when Microsoft started (good example). Who got some shares as part of wages or a bonus.
Or take Apple for instance had you invested £700 in 2007 you would now have about £100k!
Or even in a company like Thermo Fisher Scientific- same thing, if you invested say that same £700 at IPO you would have well over £20k
Other examples include Amazon at $18/share, lol

Novartis is not the only news we are expecting! There is a lot going on behind the scenes at the company. They have even taken on sales and marketing people- so it will be I retesting couple of months imo

MM'S retraced/tree shock to release shares.
There were more buys than sells today and good volume! We have sold shares at up to 2.50 p

The seller in my opinion has been both a big seller and/or the mm's shorting!

So, ask yourself why? I think the share was kept in a range in order to keep the average share price in that range. So, why is this?

This is because the volume has been low, a little chum from placement, some pi's who bought between 1.60p-1.90p

But I also think that that pays in the hands of someone/those who would like the option to buy the company on the cheap!

notice that IP Group have 29.5% and they have been buying but being careful to stay under that magic number. This is because 30% is. Magic number and triggers things (I'll leave it to you to research), but for a few pennies they have options!

Now there are other big holders. It none who are close enough to 30%.

Now there are enough big shareholders who can influence or even act as a mm.

So, point is- this imo will be huge and there are those who would take your shares to build a bigger stake and it will not be long before DMTR starts getting courted for a buyout!

Watch this space!

Just shaking out the 10&30%ers!
Nothing has changed and news on its way!
There is a lot happening at the company and they will tell us soon enough!

Correction- Alphabet

Or could Google be sniffing?

PI's can see what is happening here! Let's build on this!

It is my belief and understanding that the selling wants a takeover! Just a thought!

Something is happening here!